- Home
- GO vs AZTA Comparison
GO vs AZTA Comparison
Compare GO & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GO
- AZTA
- Stock Information
- Founded
- GO 1946
- AZTA 1978
- Country
- GO United States
- AZTA United States
- Employees
- GO N/A
- AZTA N/A
- Industry
- GO Food Chains
- AZTA Industrial Machinery/Components
- Sector
- GO Consumer Staples
- AZTA Technology
- Exchange
- GO Nasdaq
- AZTA Nasdaq
- Market Cap
- GO 1.7B
- AZTA 1.4B
- IPO Year
- GO 2019
- AZTA 1995
- Fundamental
- Price
- GO $16.00
- AZTA $32.23
- Analyst Decision
- GO Hold
- AZTA Buy
- Analyst Count
- GO 12
- AZTA 4
- Target Price
- GO $17.17
- AZTA $42.00
- AVG Volume (30 Days)
- GO 2.9M
- AZTA 654.4K
- Earning Date
- GO 11-04-2025
- AZTA 11-11-2025
- Dividend Yield
- GO N/A
- AZTA N/A
- EPS Growth
- GO N/A
- AZTA N/A
- EPS
- GO 0.08
- AZTA N/A
- Revenue
- GO $4,511,376,000.00
- AZTA $668,821,000.00
- Revenue This Year
- GO $11.29
- AZTA N/A
- Revenue Next Year
- GO $5.59
- AZTA $4.18
- P/E Ratio
- GO $192.49
- AZTA N/A
- Revenue Growth
- GO 8.47
- AZTA 12.46
- 52 Week Low
- GO $10.26
- AZTA $23.91
- 52 Week High
- GO $21.67
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- GO 44.32
- AZTA 51.91
- Support Level
- GO $15.77
- AZTA $30.81
- Resistance Level
- GO $16.99
- AZTA $33.09
- Average True Range (ATR)
- GO 0.65
- AZTA 1.14
- MACD
- GO 0.01
- AZTA 0.19
- Stochastic Oscillator
- GO 52.86
- AZTA 57.66
About GO Grocery Outlet Holding Corp.
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.